Navigating AI Investments and FDA Regulations in Healthcare

There’s been a lot of discussion about health insurance over the last week. And one practice could be seeing more oversight: the use of artificial intelligence in coverage decisions. Plus, the FDA issues final guidance for makers of AI-enabled medical devices so they can now update their software after approval. And it was a good year for health tech startups — after a not-so-good year in 2023 — especially for those with the letters “AI” attached to their business. Our regular contributor Christina Farr, managing director with Manatt Health, joins Marketplace’s Meghan McCarty Carino to discuss the news.